RIGL Dec 2024 1.000 call
| Previous Close | 0.2700 |
| Open | 0.2700 |
| Bid | 0.1000 |
| Ask | 1.0000 |
| Strike | 1.00 |
| Expire Date | 2024-12-20 |
| Day's Range | 0.2700 - 0.2700 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 158 |
PR NewswireRigel Announces Presentations at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced upcoming presentations from their commercial and clinical-stage hematology and oncology portfolio at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting and European Hematology Association (EHA) 2024 Hybrid Congress. The ASCO Annual Meeting is being held online and in person in Chicago, Illinois from May 31 to June 4, 2024. The EHA2024 Congress is being held online and in person in Madrid, Spain from June 13 to June 16,
ZacksRigel (RIGL) Upgraded to Buy: Here's What You Should Know
Rigel (RIGL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Simply Wall St.Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Analysts Are Pretty Bullish On The Stock After Recent Results
The analysts might have been a bit too bullish on Rigel Pharmaceuticals, Inc. ( NASDAQ:RIGL ), given that the company...
